Hims & Hers spotlights increased year-over-year and 2023 Q4 revenue

by shopidea.net
0 comment

Direct-to-consumer virtual care company Hims & Hers Health reported fourth-quarter total revenue of $246.6 million, compared to $167.2 million in the fourth quarter of 2022, and 2023 year-over-year total revenue of $872.0 million. reported total revenue of $526.9 million in 2022, compared to $526.9 million.

The San Francisco-based company reported fourth-quarter net income of $1.2 million, compared to a net loss of $10.9 million in the fourth quarter of 2022.

Net loss for 2023 was $23.5 million, compared to $65.7 million a year earlier.

The company’s gross margin increased from 79% in Q4 2022 to 83% in Q4 2023, compared to annual gross profit growth of 82% in 2023 from 78% in 2022. The same is true.

Adjusted EBITDA was $20.6 million in the fourth quarter of 2023 compared to $3.9 million in the fourth quarter of 2022, resulting in a loss of $49.5 million for the year and a loss of $15.8 million in 2022.

The company reported that the number of subscribers reached 1.5 million in the fourth quarter of 2023, an increase of 48% year-on-year.

“Our strong performance in 2023 reflects the strength of the Hims & Hers brand and strong execution across the organization,” co-founder and CEO Andrew Dadham said in a statement. I’m emphasizing that.”

“In 2024, our continued focus on building personalized, accessible treatments in each of our core specialties will drive us to exceed $1 billion in revenue and achieve our first full-year milestone. We expect to achieve positive net income and believe this approach will meaningfully break down the barriers to maintaining the status quo.” It will be available to 10 million subscribers. ”

bigger trends

him and her completed its merger with special acquisition purpose company (SPAC) Oaktree Acquisition in 2021 and began trading on the New York Stock Exchange at $9.80 per share.

Since then, the company has stock price It reached a high of $23.99 in 2021 and is currently hovering around $14.62 per share.

in In the third quarter of last year, the company reported revenue of $226.7 million, up 57% year-over-year, compared to $144.8 million in the same period in 2022. We announced the start of beta testing for our AI-enabled products. The provider, which provides anonymized data points generated from the company’s customer database, helps patients suffering from anxiety and depression identify appropriate treatments based on their individual needs.

In November, Hims & Hers Chief Medical Officer Dr. Patrick Carroll said: Mobi Health News We will have an exclusive interview talking about the company’s EMR and MedMatch.

“What we do is we have millions of data points coming from completely vertical systems, so we have insights into patient demographics, past medical history, medications. ” Carol said. “So when you have these millions of data points, you can imagine that it’s like a treasure trove for people in the machine learning and AI field.”

You may also like

Leave a Comment